Pfizer (PFE) Other Working Capital Changes (2009 - 2026)

Pfizer (PFE) has reported Other Working Capital Changes for 2 consecutive years, with $42.0 million the latest figure, recorded in Q4 2010.

• On a quarterly basis, Other Working Capital Changes fell 90.6% year-over-year to $42.0 million in Q4 2010; TTM through Dec 2010 was -$19.0 million, a 109.55% decrease from a year earlier, with the FY2010 full-year figure at -$19.0 million, down 109.55% from the prior year.
• Other Working Capital Changes was $42.0 million for Q4 2010 at Pfizer, up from $31.0 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $6.0 billion in Q3 2024 and troughed at $36.0 million in Q3 2025.
• A 5-year average of $3.0 billion and a median of $3.1 billion in 2022 frame the typical range for Other Working Capital Changes.
• The widest YoY moves for Other Working Capital Changes: up 207.77% in 2010, down 10375.0% in 2010.
• Over 2 years, Other Working Capital Changes stood at $447.0 million in 2009, then sank by 90.6% to $42.0 million in 2010.
• The last three Other Working Capital Changes figures came in at $42.0 million (Q4 2010), $31.0 million (Q4 2010), and -$411.0 million (Q3 2010), per Business Quant data.